Skip to content

Periodontal Phenotype Study (Tooth Extraction)

Periodontal Phenotype and Supracrestal Soft Tissue Dimentions - Clinical Correlations and Their Impact on Post-extraction Volumetric Changes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02668289
Enrollment
42
Registered
2016-01-29
Start date
2016-01-31
Completion date
2020-06-15
Last updated
2022-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tooth Extraction Status Nos

Brief summary

The purpose of this trial is to determine the correlations between various tissue dimensions and the changes that occur following a single-tooth dental extraction in human adults. 65 adult subjects who are in need of dental extractions will be recruited. Clinical measurements will be gathered prior to and immediately following the single tooth extraction. There will be a 2-week post-operative visit to assess healing and a 14-week follow-up for photographic documentation and clinical measurements of the extraction area.

Detailed description

Periodontal phenotype, also known as periodontal biotype, has been recognized as one of the key factors that may potentially impact the outcome of a variety of esthetic restorative procedures. With the increasing esthetic demand of patients in the context of tooth replacement therapy in the anterior esthetic zone, the ability to determine the prognostic value and the influence on treatment outcomes of this parameter has become a critical component of contemporary treatment planning. Periodontal phenotype encompases bone morphotypes, shapes of the teeth, morphologic characteristics of the gingiva and the periodontium.

Interventions

OTHERconsent

At the initial screening examination, each subject will receive an informed consent form. Prior to signing the informed consent, one of the investigators or qualified staff will thoroughly discuss participation in the study with each subject, allocating time for questions and answers.

OTHERScreening

At the initial screening examination, complete medical and dental history will be obtained to verify eligibility.

OTHERXray

each subject will undergo site-specific oral radiographic exam (new periapical radiographs will be obtained if needed) to evaluate potential study sites.

OTHERPVS Impressions

PVS impressions of the arch of interest will be obtained in order perform volumetric analysis of the area of interest.

Intraoral photographs will also be taken and subsequent study visits will be planned.

OTHERCBCT

The patient will then be sent to the Department of Radiology at the College of Dentistry for a baseline CBCT and follow-up at 14 week CBCT. These CBCT's will be utilized to evaluate the hard tissue volume in comparison to the clinical volume of soft tissue.

OTHERAnesthesia

After appropriate local anesthetic is administered and anesthesia is achieved, the buccal tissue thickness will be measured and recorded.

PROCEDUREExtraction

After the pre-extraction baseline measurements are recorded and adequate anesthesia is confirmed, minimally invasive extraction procedures will be initiated. All extractions will be performed by residents in the UI CoD Periodontics advanced education program.

Measuring soft tissue dimensions, bone thickness prior to and immediately after extraction and then after appropriate healing time frames.

Sponsors

Gustavo Avila-Ortiz DDS, MS, PhD
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Age: 18 to 75 years * Gender: No restriction * Subjects must require a single-rooted tooth extraction (Tooth deemed as periodontally and/or restoratively hopeless) in the maxillary anterior region (first premolar to first premolar) * Subjects must be able and willing to follow instructions related to the study procedures * Subjects must have read, understood and signed an informed consent form

Exclusion criteria

* More than 1 mm of recession present on the tooth planned for extraction and inclusion in the study * Reported allergy or hypersensitivity to any of the products to be used in the study * Severe hematologic disorders, such as hemophilia or leukemia * Active severe infectious diseases that may compromise normal healing * Liver or kidney dysfunction/failure * Currently under cancer treatment or within 18 months from completion of radio- or chemotherapy * Subjects who have a long-term history of oral bisphosphonate use (i.e. 10 years or more) * Subjects with a history of IV bisphosphonates * Subjects with uncontrolled diabetes, defined as Hba1c \> 7.0 * Subjects with severe metabolic bone diseases, such as Paget's disease of bone, will be excluded * Pregnant women or nursing mothers * Heavy smokers: Subjects who have smoked \>10 cigarettes per day within 6 months of study onset * Concomitant medications: Subjects on concomitant drug therapy for systemic conditions that may affect the outcomes of the study will not be included in the study. NOTE: Occasional, short-term use (7-14 days) of analgesics or common cold medications is permitted. Use of such medications will be reviewed and recorded by the investigator. \- Any other non-specified reason that from the point of views of the investigators will make a candidate not a suitable subject for the study (e.g. limited mouth opening).

Design outcomes

Primary

MeasureTime frameDescription
Percentage change in tissue volume - Rank Correlations14 weeksFor the purpose of this study, a 10-20% reduction in the volume must detectable. Pearson correlations will be used to assess associations if appropriate and Spearman rank correlations will be considered if needed.

Secondary

MeasureTime frameDescription
Probing Depths of soft tissue dimensions14 weekssupracrestal soft tissue dimensions will be evaluated
bone thickness ( facial and lingual) - Correlations14 weeksAnalogous correlational approaches, supplemented by regression methods, will be used to assess the relationships between measurements made by CBCT with those derived from volumetric analysis of casts.
soft tissue thickness (facial and lingual) -correlations14 weekscorrelations among the periodontal phenotype and the supracrestal soft tissue dimensions will be evaluated.

Other

MeasureTime frameDescription
width of keratinized gingiva14 weekssupracrestal soft tissue dimensions will be evaluated

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026